FIELD: medical biotechnology. SUBSTANCE: objective of invention is to activate apoptine-induced apoptosis by a variety of agents causing transformation of normal cell or cell disposed to cancer diseases, said apoptine, or so called VP3, being viral protein isolated from chicken anemia virus. Treatment of above-named cells with agents inducing development of tumor will activate apoptine-induced apoptosis leading to death of potentially malignant cells. Agents possessing tumor-generating activity can be examined by their expression in normal cells and their ability to cause apoptine- induced apoptosis. EFFECT: extended choice of agents useful in diagnosis and therapy of tumors. 12 cl, 10 dwg
Title | Year | Author | Number |
---|---|---|---|
GENE DELIVERY VECTOR CAPABLE TO INDUCE CELL APOPTOSIS | 1998 |
|
RU2252255C2 |
RECOMBINANT PLASMID DNA pcDNA4-Apo-2NLS2 CARRYING SYNTHETIC GENE OF APOPTIN PROTEIN INDUCING p53-INDEPENDENT PROGRAMMED TUMOUR CELL DEATH | 2013 |
|
RU2541777C1 |
RECOMBINANT PLASMID DNA pGEM-Puro-DS-Apo COMPRISING SYNTHETIC APOPTIN GENE FLANKED BY SEQUENCES OF VACCINIA VIRUS GENOME OF ISLAND C10L-C12L, AND RECOMBINANT STRAIN VVdGF-ApoS24/2 OF VACCINIA VIRUS PRODUCING APOPTIN | 2012 |
|
RU2492238C1 |
METHOD OF OBTAINING SYSTEM OF DIRECTED DELIVERY OF PROTEIN MOLECULES (ONCOLYTIC PROTEINS) INTO TUMOUR CELLS BASED ON ACTIVATED LYMPHOCYTES | 2013 |
|
RU2552609C1 |
ADENOVIRUS-RECOMBINANT CARRYING ADENOVIRAL VECTOR STRUCTURE (VARIANTS), METHOD FOR RECOVERY FUNCTION OF PROTEIN P53 IN TUMOR CELL WITH DEFICIENCY OF NATURAL P53, METHOD FOR PRODUCING ADENOVIRUS-RECOMBINANT | 1994 |
|
RU2222600C2 |
METHOD OF APOPTOSIS STIMULATION | 2006 |
|
RU2340349C2 |
SYNTHETIC MUTANT GENE RB (VARIANTS), SYNTHETIC MUTANT GENE P53, PLASMID (VARIANTS), MUTANT PROTEIN (VARIANTS), METHOD OF INHIBITION OF CELLULAR PROLIFERATION (VARIANTS), METHOD OF INDUCTION OF APOPTOSIS | 1995 |
|
RU2192431C2 |
MULTIPURPOSE CANCER-SPECIFIC PROMOTERS AND USING THEM IN ANTI-CANCER THERAPY | 2013 |
|
RU2539764C2 |
IMMORTALIZED CHICKEN EMBRYO FIBROBLASTS | 2015 |
|
RU2694318C2 |
RECOMBINANT VARIOLOVACCINE VIRUS STRAIN VV-NS1-dGF PRODUCING NS1 PARVOVIRUS H-1 PROTEIN AND HAVING ONCOLYTIC ACTIVITY ON HUMAN GLIOBLASTOMA | 2018 |
|
RU2692628C1 |
Authors
Dates
2003-10-20—Published
1998-08-11—Filed